A detailed history of Ground Swell Capital, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Ground Swell Capital, LLC holds 12,025 shares of VXRT stock, worth $6,974. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,025
Holding current value
$6,974
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$0.58 - $0.99 $6,974 - $11,904
12,025 New
12,025 $10,000
Q2 2021

Aug 12, 2021

SELL
$5.06 - $10.78 $52,968 - $112,845
-10,468 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$5.64 - $23.33 $59,039 - $244,218
10,468 New
10,468 $63,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.